CISD2 and uveal melanoma: Further data indicated a significantly poorer OS in patients with high CISD2 expression in LUAD, uveal melanoma (UVM), head and neck squamous cell carcinoma (HNSC), brain lower grade glioma (LGG), kidney chromophobe (KICH), and liver hepatocellular carcinoma (LIHC) (Figure 2B).